Mersana Therapeutics Inc (MRSN)
1.96
+0.12
(+6.52%)
USD |
NASDAQ |
Nov 05, 14:39
Mersana Therapeutics Total Assets (Quarterly): 179.13M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 179.13M |
| March 31, 2024 | 198.37M |
| December 31, 2023 | 226.06M |
| September 30, 2023 | 262.90M |
| June 30, 2023 | 311.00M |
| March 31, 2023 | 296.20M |
| December 31, 2022 | 334.34M |
| September 30, 2022 | 314.85M |
| June 30, 2022 | 252.35M |
| March 31, 2022 | 258.27M |
| December 31, 2021 | 206.11M |
| September 30, 2021 | 217.59M |
| June 30, 2021 | 253.68M |
| March 31, 2021 | 247.91M |
| December 31, 2020 | 273.40M |
| September 30, 2020 | 290.13M |
| Date | Value |
|---|---|
| June 30, 2020 | 310.52M |
| March 31, 2020 | 95.86M |
| December 31, 2019 | 107.54M |
| September 30, 2019 | 121.66M |
| June 30, 2019 | 139.38M |
| March 31, 2019 | 149.39M |
| December 31, 2018 | 78.50M |
| September 30, 2018 | 94.38M |
| June 30, 2018 | 106.91M |
| March 31, 2018 | 115.76M |
| December 31, 2017 | 130.72M |
| September 30, 2017 | 142.92M |
| June 30, 2017 | 85.22M |
| March 31, 2017 | 95.01M |
| December 31, 2016 | 105.09M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
95.86M
Minimum
Mar 2020
334.34M
Maximum
Dec 2022
244.01M
Average
253.68M
Median
Jun 2021
Total Assets (Quarterly) Benchmarks
| Chimerix Inc | 178.51M |
| Cellectar Biosciences Inc | 29.38M |
| Marinus Pharmaceuticals Inc | 87.08M |
| Jaguar Health Inc | 61.46M |
| Seres Therapeutics Inc | 321.73M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 170.70M |
| Shareholders Equity (Quarterly) | 8.427M |
| Debt to Equity Ratio | 3.012 |
| Current Ratio | 2.717 |
| Net Debt Paydown Yield | -0.03% |